---
$id: https://graph.org.ai/products/commodity/51111645
$type: Product
source: UNSPSC
code: "51111645"
title: "Pralatrexate"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pralatrexate

**UNSPSC Code**: 51111645
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula C23H23N7O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A8Q8I19Q20, more generally known as pralatrexate. European Medicines Agency schedules pralatrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32989. The term PRALATREXATE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 19, no. 3, 2005, list 54. Most nations schedule pralatrexate under HS 29335995 and SITC 51576. As of Q4 2014, PRALATREXATE remains the US FDA Preferred Term for this commodity. Pralatrexate bears US NLM identifiers UMLS ID C0879404 and NCI Concept Code C2250. SMILES: C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O.

